Lowering the cut off value of an automated chlamydia enzyme immunoassay and confirmation by PCR and direct immunofluorescent antibody test.
Open Access
- 1 August 1997
- journal article
- clinical trial
- Published by BMJ in Journal of Clinical Pathology
- Vol. 50 (8) , 681-685
- https://doi.org/10.1136/jcp.50.8.681
Abstract
To increase the sensitivity of an automated chlamydia enzyme immunoassay by significantly lowering its cut off value, and to maintain specificity by confirmation with polymerase chain reaction (PCR) and direct immunofluorescent antibody test (DFA). Over five months, the cut off value of the enzyme immunoassay used to screen urogenital samples for chlamydia antigen was reduced from 80 to 10. Samples with a test value of 10 or above were further tested with a commercial PCR assay. All samples during the first three months and discrepant samples during the last two months of the study were also tested with the DFA. 3250 urogenital swabs (1246 urethral, 1335 endocervical, 669 pooled urethral/endocervical) from 1246 males and 2004 females were processed. Using the manufacturer's recommended cut off of 80, the enzyme immunoassay identified chlamydia antigen in 134 samples (4.1%). Using the lower cut off value of 10 and either PCR or DFA as the confirmatory test, Chlamydia trachomatis was identified in 178 samples (5.5%). Thus, 45 additional positive samples were identified and the confirmed detection rate was increased by 33.8% (45/133). Excluding equivocal PCR results, the concordance between DFA and PCR was 91.8%. This strategy increased the detection rate by 2.1% in men and 0.9% in women (significant only in men). In female patients, pooled urethral/endocervical swabs as a specimen gave a significantly higher yield than endocervical swabs regardless of whether the lower cut off strategy was used. This strategy of significantly lowering the cut off test value with confirmation on the same specimen by either PCR or DFA is feasible and cost effective. The use of pooled urethral/ endocervical specimens in females should be considered routinely as detection rate was significantly improved.Keywords
This publication has 12 references indexed in Scilit:
- Current methods of laboratory diagnosis of Chlamydia trachomatis infections.1997
- Under-diagnosis of female genital Chlamydia trachomatis infection.Sexually Transmitted Infections, 1996
- Comparison of an automated enzyme immunoassay with a direct fluorescent antibody test and polymerase chain reaction for the detection ofChlamydia trachomatis in diagnostic specimens from male patientsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1996
- Multiple sites for the detection of Chlamydia trachomatis in women--does it matter?1996
- Use of the polymerase chain reaction for the detection of Chlamydia trachomatis from endocervical and urine specimens in an asymptomatic low-prevalence population of womenDiagnostic Microbiology and Infectious Disease, 1994
- Expanded gold standard in the diagnosis of Chlamydia trachomatis in a low prevalence population: diagnostic efficacy of tissue culture, direct immunofluorescence, enzyme immunoassay, PCR and serology.Sexually Transmitted Infections, 1994
- Chlamydia trachomatis in women: the more you look, the more you find.Sexually Transmitted Infections, 1994
- Confirmatory Testing of Chlamydia trachomatis Syva Enzyme Immunoassay Gray Zone Specimens by Syva Direct Fluorescent Antibody TestSexually Transmitted Diseases, 1993
- Detection of Chlamydia trachomatis by the polymerase chain reaction in swabs and urine from men with non-gonococcal urethritis.Journal of Clinical Pathology, 1991
- The 7.5-kb plasmid present in Chlamydia trachomatis is not essential for the growth of this microorganismPlasmid, 1990